Multiplex PCR in Donor and Recipient Bronchoalveolar Lavage to Guide Early Antibiotic Prophylaxis Adaptation in Lung

Damien Barrau1, Geoffrey Brioude2, Alban Todesco2

  • 1Service de Médecine Intensive-Réanimation, AP-HM, Hôpital Nord, 13015 Marseille, France.

PubMed

Insights

Multiplex PCR (mPCR) in lung transplant (LT) recipients and donors significantly speeds up antibiotic prophylaxis adaptation. This method reduces the time patients receive inadequate antibiotic treatment, improving patient outcomes.

Area of Science:

  • Medical Microbiology
  • Transplant Surgery
  • Infectious Diseases

Background:

  • International guidelines advocate antibiotic prophylaxis for lung transplantation (LT).
  • Multiplex PCR (mPCR) accelerates antibiotic selection in pneumonia but its role in LT prophylaxis is unexplored.
  • Early adaptation of antibiotic prophylaxis is crucial in LT to prevent complications.

Purpose of the Study:

  • To assess if mPCR in donor and recipient bronchoalveolar lavage (BAL) enables early adaptation of antibiotic prophylaxis during LT.
  • To compare the turnaround time of mPCR versus standard microbiology for guiding LT prophylaxis.
  • To evaluate the duration of inadequate antibiotic prophylaxis in LT patients.

Main Methods:

  • Retrospective, single-center study of 41 lung transplant patients.
  • Utilized multiplex PCR (FilmArray Pneumonia Plus Panel) on donor and recipient BAL fluid.
  • Compared mPCR results and turnaround times with standard microbiology methods.

Main Results:

  • mPCR led to early antibiotic prophylaxis adaptation in 24% of patients (10/41).
  • mPCR turnaround time was significantly faster: ~1.7 hours vs. over 74 hours for standard microbiology (p < 0.001).
  • mPCR-guided adaptation reduced inadequate antibiotic prophylaxis duration by an average of 71.9 hours.

Conclusions:

  • mPCR testing of donor and recipient BAL fluid can facilitate timely adaptation of antibiotic prophylaxis in lung transplantation.
  • This approach may significantly decrease the period of inadequate antibiotic exposure.
  • mPCR offers a valuable tool for optimizing antimicrobial stewardship in lung transplant recipients.